[1] Castro M C, Wilson M E, Bloom D E.Disease and economic burdens of dengue[J]. Lancet Infect Dis, 2017, 17(3): e70-e78. [2] Chen B, Liu Q.Dengue fever in China[J]. Lancet, 2015, 385(9978): 1621-2. [3] Lai S, Huang Z, Zhou H, et al.The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data[J]. BMC Med, 2015, 13:100. [4] 赵令斋,高秀洁,庾蕾,等. 登革病毒载量和IgM抗体水平与疾病严重程度的关系[J]. 中华微生物学和免疫学杂志,2016, 36(4): 252-255. [5] Vazquez S, Hafner G, Ruiz D, et al.Evaluation of immunoglobulin M and G capture enzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections[J]. J Clin Virol, 2007, 39(3): 194-198. [6] Wei HY, Shu PY, Hung MN.Characteristics and risk factors for fatality in patients with dengue demorrhagic fever, Taiwan, 2014[J]. Am J Trop Med Hyg, 2016, 95(2): 322-327. [7] Sharp T M, Tomashek K M, Read J S, et al.A New Look at an Old Disease: Recent Insights into the Global Epidemiology of Dengue[J]. Curr Epidemiol Rep,2017,4(1):11-21. [8] Lai S, Huang Z, Zhou H, et al.The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data[J]. BMC Med, 2015, 13:100. [9] Zhao H, Zhang FC, Zhu Q, et al.Epidemiological and Virological Characterizations of the 2014 Dengue Outbreak in Guangzhou, China[J]. PLoS One, 2016, 11(6): e0156548. [10] Katzelnick LC, Gresh L, Halloran ME, et al.Antibody-dependent enhancement of severe dengue disease in humans[J]. Science, 2017, 358(6365): 929-932. [11] Murphy B R, Whitehead S S.Immune response to dengue virus and prospects for a vaccine[J]. Annu Rev Immunol, 2011, 29: 587-619. [12] Simmons C P, Farrar J J, Nguyen V, et al.Dengue[J]. N Engl J Med, 2012, 366(15): 1423-1432. [13] Prince H E, Yeh C, Lape-Nixon M.Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset[J]. Clin Vaccine Immunol, 2011, 18(11):1951-1956. [14] Falconar A K, de Plata E, Romero-Vivas C M. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated[J]. Clin Vaccine Immunol, 2006, 13(9): 1044-1051. [15] Changal K H, Raina A H, Raina A, et al.Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India[J]. BMC Infect Dis, 2016, 16(1): 715. [16] Cucunawangsih, Lugito N P, Kurniawan A. Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset[J]. BMC Infect Dis, 2015, 15:276. |